These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18351464)

  • 41. Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: significance of anti-cagA antibodies.
    Vaucher C; Janvier B; Nousbaum JB; Grignon B; Pezennec L; Robaszkiewicz M; Gouerou H; Picard B; Fauchere JL
    Clin Diagn Lab Immunol; 2000 May; 7(3):463-7. PubMed ID: 10799462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of CagA-positive infection with Helicobacter pylori antibodies of IgA class.
    Rautelin HI; Oksanen AM; Karttunen RA; Seppälä KM; Virtamo JR; Aromaa AJ; Kosunen TU
    Ann Med; 2000 Dec; 32(9):652-6. PubMed ID: 11209973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Could gastric histology be a useful marker for making decision on Helicobacter pylori eradication therapy in patients with dyspepsia?
    Arruda SM; Forones NM; Jucá NT; de Barros KS
    Arq Gastroenterol; 2009; 46(3):209-13. PubMed ID: 19918688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
    Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CagA antibodies as a marker of virulence in chilean patients with Helicobacter pylori infection.
    Harris PR; Godoy A; Arenillas S; Riera F; García D; Einisman H; Peña A; Rollán A; Duarte I; Guiraldes E; Perez-Perez G
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):596-602. PubMed ID: 14581804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
    Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
    Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CagA status in dyspeptic patients with and without peptic ulcer disease in Turkey: association with histopathologic findings.
    Demirtürk L; Ozel AM; Yazgan Y; Solmazgül E; Yildirim S; Gültepe M; Gürbüz AK
    Helicobacter; 2001 Jun; 6(2):163-8. PubMed ID: 11422473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Local and systemic immune and inflammatory responses to Helicobacter pylori strains.
    Bhat N; Gaensbauer J; Peek RM; Bloch K; Tham KT; Blaser MJ; Perez-Perez G
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1393-400. PubMed ID: 16339062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients.
    Hirai M; Azuma T; Ito S; Kato T; Kohli Y; Fujiki N
    Int J Cancer; 1994 Jan; 56(1):56-60. PubMed ID: 8262677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori endemic and gastric disease.
    Siavoshi F; Malekzadeh R; Daneshmand M; Ashktorab H
    Dig Dis Sci; 2005 Nov; 50(11):2075-80. PubMed ID: 16240218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development.
    Douraghi M; Talebkhan Y; Zeraati H; Ebrahimzadeh F; Nahvijoo A; Morakabati A; Ghafarpour M; Esmaili M; Bababeik M; Oghalaie A; Rakhshani N; Hosseini ME; Mohagheghi MA; Mohammadi M
    Digestion; 2009; 80(3):200-7. PubMed ID: 19752557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
    Yang G; Hu F; Jia J
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytotoxin-associated gene A-positive Helicobacter pylori infection in the elderly. Association with gastric atrophy and intestinal metaplasia.
    Pilotto A; Rassu M; Bozzola L; Leandro G; Franceschi M; Furlan F; Meli S; Scagnelli M; Di Mario F; Valerio G
    J Clin Gastroenterol; 1998 Jan; 26(1):18-22. PubMed ID: 9492857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
    Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serologic detection of CagA positive Helicobacter pylori infection in a northern Italian population: its association with peptic ulcer disease.
    Orsini B; Ciancio G; Surrenti E; Macrí G; Biagini MR; Milani S; Surrenti C
    Helicobacter; 1998 Mar; 3(1):15-20. PubMed ID: 9546113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helicobacter pylori antibodies and gastric cancer: a gender-related difference.
    Janulaityte-Günther D; Kupcinskas L; Pavilonis A; Valuckas K; Percival Andersen L; Wadström T
    FEMS Immunol Med Microbiol; 2005 May; 44(2):191-5. PubMed ID: 15866215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia.
    Peters TM; Owen RJ; Slater E; Varea R; Teare EL; Saverymuttu S
    J Clin Pathol; 2001 Mar; 54(3):219-23. PubMed ID: 11253135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune responses to Helicobacter pylori infection in children with intellectual disabilities.
    Douraghi M; Goudarzi H; Nateghi Rostami M; Nikmanesh B
    Res Dev Disabil; 2012; 33(2):663-9. PubMed ID: 22186633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan.
    Maeda S; Kanai F; Ogura K; Yoshida H; Ikenoue T; Takahashi M; Kawabe T; Shiratori Y; Omata M
    Dig Dis Sci; 1997 Sep; 42(9):1841-7. PubMed ID: 9331145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease.
    Lenzi C; Palazzuoli A; Giordano N; Alegente G; Gonnelli C; Campagna MS; Santucci A; Sozzi M; Papakostas P; Rollo F; Nuti R; Figura N
    World J Gastroenterol; 2006 Dec; 12(48):7815-20. PubMed ID: 17203526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.